<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58">
 <label>58</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kansagra</surname>
    <given-names>AJ</given-names>
   </name>
   <name>
    <surname>Frey</surname>
    <given-names>NV</given-names>
   </name>
   <name>
    <surname>Bar</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Laetsch</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Carpenter</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Savani</surname>
    <given-names>B</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation</article-title>. 
  <source>Biol Blood Marrow Transplant</source> (
  <year>2019</year>) 
  <volume>25</volume>(
  <issue>3</issue>):
  <page-range>e76–85</page-range>.  
  <pub-id pub-id-type="doi">10.1016/j.bbmt.2018.12.068</pub-id>
 </mixed-citation>
</ref>
